multiple-sclerosis

Documents about multiple-sclerosis

• Implementation Intention for Physical Activity in Multiple Sclerosis#877511ClinicalTrials.gov
• Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies#877602ClinicalTrials.gov
• Tenofovir Alafenamide for Treatment of Symptoms and Neuroprotection in Relapsing Remitting Multiple Sclerosis#880207ClinicalTrials.gov
• Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis#880990ClinicalTrials.gov
• Self-Directed Positive Psychology Intervention for Newly Diagnosed Multiple Sclerosis#898370ClinicalTrials.gov
• TRAIN-BW: Backward Walking Training in Multiple Sclerosis#903371ClinicalTrials.gov
• 3D Phase Sensitive Inversion Recuperation MRI to Detect and Characterize Multiple Sclerosis Spinal Cord Lesions#910633ClinicalTrials.gov
• Oral Cladribine in Early Multiple Sclerosis (MS)#910832ClinicalTrials.gov
• Myotonometer Analyses of Muscles in Multiple Sclerosis Patients With Dysphagia#912315ClinicalTrials.gov
• Creating Satisfying Engagement in Daily Life Through Coaching for People With Multiple Sclerosis#912904ClinicalTrials.gov
• The Effect of Transcutaneous Electrical Nerve Stimulation (TENS) in Multiple Sclerosis#967066ClinicalTrials.gov
• Digitalization of Neurofunctional Tests Via a Mobile Application DAMS for Multiple Sclerosis Patients#967763ClinicalTrials.gov
• Dataset of multi-field functional electrical stimulation with Fesia Grasp for hand rehabilitation in Multiple Sclerosis: randomized controlled trial outcomes#680410Repositorio Institucional de la Universidad de Burgos (RIUBU)
• Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis#875261ClinicalTrials.gov
• MSPT Device Usability Study#807725ClinicalTrials.gov
• Rebif® Pregnancy Registry#859389ClinicalTrials.gov
• Urodynamic Voiding Patterns in Multiple Sclerosis#624725HAL (France)
• Sexual Dysfunction, Disability and Quality of Life in Patients With Multiple Sclerosis (MS)#806032ClinicalTrials.gov
• Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients#806670ClinicalTrials.gov
• Validation of Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS)#830928ClinicalTrials.gov
• The Effect of Telerehabilitation on Balance in People With Multiple Sclerosis#834961ClinicalTrials.gov
• Low-Load Blood Flow Restriction on Patients With Multiple Sclerosis#835720ClinicalTrials.gov
• Examining the Effects of a Telehealth Self-management Intervention in Multiple Sclerosis#840047ClinicalTrials.gov
• Examining the Impact of an Online, Non-restrictive Diet Among Persons With Multiple Sclerosis#840527ClinicalTrials.gov
• Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue#841182ClinicalTrials.gov
• Effects of Sailing and Cooing in the Quality of Life of Multiple Sclerosis Individuals#844081ClinicalTrials.gov
• Cognitive Behavioral Therapy for Insomnia to Address Insomnia Symptoms in People With Multiple Sclerosis#845251ClinicalTrials.gov
• Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis#857917ClinicalTrials.gov
• Maximizing Outcome of Multiple Sclerosis Transplantation#867353ClinicalTrials.gov
• Measuring Active Microglia in Progressive Multiple Sclerosis#868913ClinicalTrials.gov
• Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)#871535ClinicalTrials.gov
• Use of a Smartphone Application to Predict the Prognosis in Patients With Newly Diagnosed Multiple Sclerosis.#871668ClinicalTrials.gov
• Therapy Optimization in Multiple Sclerosis (MS)#873601ClinicalTrials.gov
• A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis#892192ClinicalTrials.gov
• Intermittent Fasting and Mediterranean Diet in Patient With Multiple Sclerosis#903714ClinicalTrials.gov
• Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With BG00012#909913ClinicalTrials.gov
• Symptomatic Trigeminal Neuralgia Attributed to Multiple Sclerosis - a Prospective Study in 60 Patients#914182ClinicalTrials.gov
• Sport, Rehabilitation and Nutrition in Multiple Sclerosis: The LINUS Project#966875ClinicalTrials.gov
• Dietary adherence and disability evolution in multiple sclerosis: an exploratory 12-month prospective cohort study#402366Gestión del Repositorio Documental de la Universidad de Salamanca
• Impact of Vitamin A on Gene Expression, in Multiple Sclerosis Patient#830824ClinicalTrials.gov
• Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health Care#910193ClinicalTrials.gov
• “Pharmacogenetics of siponimod: A systematic review” by Díaz-Villamarín et al. – Information is power#379142Repositorio Institucional de la Universidad de Burgos (RIUBU)
• Validity and Reliability of the L Test in Single and Dual Task Conditions in Multiple Sclerosis#899027ClinicalTrials.gov
• Effectiveness of immersive and non-immersive virtual reality interventions on cognitive function in people with multiple sclerosis: a systematic review#395150Gestión del Repositorio Documental de la Universidad de Salamanca
• A Study Utilising Data From European Union (EU) National Multiple Sclerosis (MS) Registries to Assess the Incidence of Anti-Natalizumab Antibody Among Participants Who Receive Subcutaneous Administration of Natalizumab for Treatment of Relapsing-remitting Multiple Sclerosis (RRMS)#860611ClinicalTrials.gov
• A Real-world Study to Assess the Use of Siponimod in Spain to Treat Patients With Secondary Progressive Multiple Sclerosis#141136ClinicalTrials.gov
• Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)#332727ClinicalTrials.gov
• Unlocking the healing power of Berberine: A promising aid for multiple sclerosis#478487Europe PMC
• Markers of Immune Activation in Patients with Multiple Sclerosis#626492Rīga Stradiņš University Institutional Repository Dataverse Dataverse OAI Archive
• Reduced Childhood Outdoor Exposure Raises Pediatric Multiple Sclerosis (PedMS) Risk#642364Europe PMC